Evidence map›Paper›PMID 22652647›Full record

ArticleFrontiers in bioscience (Elite edition)2012

Cigarette smoke enhances chemotaxis via acetylation of proline-glycine-proline.

Matthew Thomas Hardison, Michael David Brown, Robert James Snelgrove, James Edwin Blalock, Patricia Jackson

Open access · bronzeAbstract read
In one paragraph

Article in Frontiers in bioscience (Elite edition), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2020
    Article
  3. Review
  4. Article
  5. The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease.European respiratory review : an official journal of the European Respiratory Society · 2018
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Leukotriene A4 hydrolase: the Janus enzyme shows its ugly side in smokers.American journal of respiratory and critical care medicine · 2014
    Article
  11. Article
  12. Article
  13. MMP generated matrikines.Matrix biology : journal of the International Society for Matrix Biology
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew Thomas HardisonDepartment of Medicine, University of Alabama at Birmingham 1918 University Blvd., Birmingham, AL 35294, USA.
Michael David Brown
Robert James Snelgrove
James Edwin Blalock
Patricia Jackson
University of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI David M. Bedwell · 2007 to 2026
$23.0M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
PROJECT 4 - POLYPHENOLS AND DAMAGE IN THE EYEP50AT000477 · NCCIH · PURDUE UNIVERSITY WEST LAFAYETTE · PI WEAVER, CONNIE MARIE · 2000 to 2010
$15.0M
Center for Nutrient-Gene Interaction in Cancer PreventionU54CA100949 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2003 to 2008
$9.7M
UAB Skin Diseases Research CenterP30AR050948 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELMETS, CRAIG A · 2004 to 2013
$5.5M
Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation inR01HL090999 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2007 to 2010
$1.5M
Therapeutics for Chronic Lung Diseases: Antagonists of PGP, Chemokines and CXCRR01HL087824 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2009 to 2010
$823k
SPECT: POLYPHENOLS: SOY &MENARCHE,0STEOPOR, GREEN TEA&BREAST CANCER, NEURODIS S10RR019231 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2004 to 2004
$465k
NCCIH NIH HHS P50 AT000477NCCIH NIH HHS P50 AT00477NCI NIH HHS P30 CA013148NCI NIH HHS P30CA13148NCI NIH HHS U54 CA100949NCI NIH HHS U54CA100949NCRR NIH HHS RR19231NCRR NIH HHS S10 RR019231NHLBI NIH HHS HL07783NHLBI NIH HHS HL087824NHLBI NIH HHS HL090999NHLBI NIH HHS R01 HL087824NHLBI NIH HHS R01 HL090999NIAMS NIH HHS P30 AR050948NIAMS NIH HHS P30AR050948NIDDK NIH HHS P30 DK072482NIDDK NIH HHS P30 DK079337PHS HHS P30 DKO72482Wellcome Trust 082727/Z/07/ZWellcome Trust 095707
6 · The paper itself

Abstract

Several chronic lung diseases have been linked to cigarette smoking (Chronic Obstructive Pulmonary Disease (COPD), and cancer are associated with increased tobacco use). We recently described a collagen fragment, proline-glycine-proline (PGP), chemotactic for neutrophils, that appears to play a role in COPD, cystic fibrosis, and bronchiolitis obliterans syndrome. PGP can exist in either its native or acetylated form (NAcPGP), although the mechanism of N-terminal-acetylation remains unknown. This work investigates the possibility that cigarette smoke (CS) and its components acetylate PGP, describing a possible mechanism for some of the chronic inflammation seen in tobacco-associated disease. CSE and CSC (3.56 and 12.38 ng/ml NAcPGP respectively, p less than 0.01) and its components (acrolein, acetaldehyde, and methyl glyoxal) acetylated PGP (0.51, 1.03, and 0.23 ng/ml NAcPGP, p less than 0.01). Both N-acetyl-cysteine and carbocysteine (scavengers of reactive aldehydes) blocked chemical acetylation of PGP by CS (100 percent and 97 percent inhibition, respectively, p less than 0.01). NAcPGP is more chemoattractive to neutrophils, and less susceptible to degradation by Leukotriene-A4-Hydrolase (detected in the lung). These experiments propose a mechanism for the increased neutrophil recruitment seen in smoking-associated lung diseases.

Indexed as

Chemotaxis, LeukocyteSmokeAcetylationAcetylcysteineCarbocysteineHumansNeutrophilsNicotianaOligopeptidesProlineAcetylcysteineCarbocysteineOligopeptidesProlineprolyl-glycyl-prolineSmoke

Identifiers

PMID22652647
PMCPMC5796637
OpenAlexW2344829270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.